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Pitx2 is a homeobox transcription factor involved in left–right signaling during embryoge-
nesis. Disruption of left–right signaling in mice within its core nodal/lefty cascade, results
in impaired expression of the last effector of the left–right cascade, Pitx2, leading in many
cases to absence or bilateral expression of Pitx2 in lateral plate mesoderm (LPM). Loss
of Pitx2 expression in LPM results in severe cardiac malformations, including right cardiac
isomerism. Pitx2 is ﬁrstly expressed asymmetrically in the left but not right LPM, before
the cardiac crescent forms, and subsequently, as the heart develops, becomes conﬁned to
the left side of the linear heart tube. Expression of Pitx2 is remodeled during cardiac loop-
ing, becoming localized to the ventral portion of the developing ventricular chambers, while
maintaining a distinct left-sided atrial expression.The importance of Pitx2 during cardiogen-
esis has been illustrated by the complex and robust cardiac defects observed on systemic
deletion of Pitx2 in mice. Lack of Pitx2 expression leads to embryonic lethality at mid-term,
and Pitx2-deﬁcient embryos display isomeric hearts with incomplete closure of the body
wall. However, whereas the pivotal role of Pitx2 during cardiogenesis is well sustained,
its putative role in the fetal and adult heart is largely unexplored. Recent genome-wide
association studies have identiﬁed several genetic variants highly associated with atrial
ﬁbrillation (AF). Among them are genetic variants located on chromosome 4q25 adjacent
to PITX2. Since then several transgenic approaches have provided evidences of the role
of the homeobox transcription factor PITX2 and atrial arrhythmias. Here, we review new
insights into the cellular and molecular links between PITX2 and AF.
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Cardiac arrhythmia can be deﬁned as a deviation from the nor-
mal heart rate and/or rhythm under physiological circumstances
which are thus reﬂected on speciﬁc ECG patterns (Bellet, 1971).
Atrial arrhythmias may be regular, as in the case of ﬂutter or
monomorphic tachycardia, or irregular, as in the case of ﬁbrilla-
tion or polymorphic tachycardia (Gussak and Antzelevitch, 2008).
We focus herein on atrial ﬁbrillation (AF), the most prevalent
type of arrhythmia in humans. AF is characterized by unco-
ordinated atrial activation with consequent weakening of atrial
mechanical function with intact AV conduction (Gussak and
Antzelevitch, 2008). AF prevalence ranges from 1% in young
adults to >10% of those over 80 years old (Fuster et al., 2001)
and is frequently associated with hypertension, coronary disease,
valvular diseases, and cardiomyopathies (Kannel et al., 1998),
yet in 10–20% of AF patients, no underlying disease is found
(Brand et al., 1985), i.e., idiopathic or lone AF. Great insights
have been gained concerning the cellular and molecular mech-
anisms that underlie AF (Schotten et al., 2011; Wakili et al., 2011).
Enhanced automaticity in one or several rapidly depolarizing foci
leads to AF (Haissaguerre et al., 1998), being frequently located
within the superior pulmonary veins, and more rarely within
the superior vena cava or coronary sinus (Moe and Abildskov,
1959). Alternatively, multiple wave fronts propagate within the
atria, resulting in derived wavelets that self-perpetuate (Arnar
et al., 2006). However, the molecular substrates of AF remain
obscure.
Although AF is the most prevalent type of arrhythmia, its
genetic etiology remains elusive. The ﬁrst AF genetic locus was
reported by Brugada et al. (1997) identifying linkage to chromo-
some 10q22–q24 and soon thereafter Chen et al. (2003) identify
a mutation in KCNQ1. Mutations in KCNQ1 have been subse-
quently conﬁrmed (Ellinor et al., 2007) as well as in other ion
channels including KCNE2, KCNE3, KCNJ2, KCNA5, and SCN5A
(Ellinor et al., 2004;Mc Nair et al., 2004;Yang et al., 2004; Xia et al.,
2005). Surprisingly,mutations in ion channels would underlie less
1% of AF cases.
The advent of new genetic strategies, in particular genome-
wide association studies (GWAS),has shednew light on the genetic
bases of arrhythmogenic syndromes and the identiﬁcationof novel
disease-causing genes (Larson et al., 2007). GWAS have identi-
ﬁed several genetic variants highly associated with AF, which are
located at 9p21, 1q21, 16q22, and 4q25, respectively. On chromo-
some 9p21, no candidate gene has been linked to AF, and thus
its relevance awaits further experimental and functional evidence
(Larson et al., 2007). Distinct genetic variants at 1q21 are linked
to KCNN3, a potassium channel involved in atrial repolarization
(Ellinor et al., 2011) and IL6R, a gene involved in inﬂammatory
response (Schnabel et al., 2011), respectively. Genetic variants at
16q22 are linked to ZFHX3, a zinc ﬁnger homeobox transcription
factor involved in liver gene expression (Gudbjartsson et al., 2009).
However, in both cases 1q21 and 16q22 risk variants, their role
in AF remains obscure. Finally, genetic variants on chromosome
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4q25 which are strongly associated with lone AF in three distinct
populations of European descent (Gudbjartsson et al., 2007) map
adjacent to PITX2, which is known to have a critical function in
establishing left–right asymmetry (Gage et al., 1999; Lin et al.,
1999) and plays a critical role in cardiac development (Campione
et al., 1999, 2001; Franco and Campione, 2003) and thus support-
ing the notion that impaired function of PITX2 might underlie AF
(Gudbjartsson et al., 2009).
Pitx2 is a homeobox transcription factor involved in left–right
signaling during embryogenesis (Gage et al., 1999; Lin et al.,
1999). Disruption of left–right signaling in mice within its core
nodal/lefty cascade (Blum et al., 1999; Hamada et al., 2001; Bam-
forth et al., 2004) results in impaired expression of Pitx2, the
last effector of the left–right cascade, being absent or bilateral
expressed in lateral plate mesoderm (LPM). Loss of Pitx2 expres-
sion in LPM results in severe cardiac malformations, including
transposition of the great arteries, double-outlet right ventricle,
and right cardiac isomerism (Gage et al., 1999; Lin et al., 1999).
However, whereas the pivotal role of Pitx2 during cardiogenesis is
well sustained, its putative role in the fetal and adult heart is largely
unexplored.
The Pitx2 gene encodes three distinct isoforms, Pitx2a, Pitx2b,
and Pitx2c, through alternative splicing and distinct promoter
usage (Schweickert et al., 2000). Pitx2c is the most prominent
isoform in the developing mouse heart and only weak and tran-
sient expression of Pitx2a is observed during early embryonic
(E9.5–E12.5) stages,whereas Pitx2bdisplays progressively decreas-
ing expression in embryonic and fetal stages (D. Franco and A.
Aranega, unpublished data). In man, a fourth isoform, PITX2D is
also expressed, which acts as a dominant negative isoform (Cox
et al., 2002). PITX2 mutations are linked to Axenfeld–Rieger syn-
drome, which is characterized by abnormal morphogenesis of the
anterior segment of the eye, variable degree of maxillary hypopla-
sia, skeletal abnormalities, and abdominal defects (Hjalt and Sem-
ina, 2005). In rodents and avian, Pitx2 displays a highly dynamic
expression proﬁle during cardiogenesis. Pitx2 is initially expressed
asymmetrically in the left but not right LPM, before the cardiac
crescent forms, and subsequently, as the heart develops, becomes
conﬁned to the left side of the linear heart tube (Campione et al.,
1999, 2001; Franco and Campione, 2003). Pitx2 expression is later
remodeled during cardiac looping, becoming conﬁned to the ven-
tral portion of the forming ventricular chambers, while keeping
left-sided atrial expression (Campione et al., 2001). With further
development, Pitx2 is down-regulated in the ventricular cham-
bers, while high and robust expression of Pitx2 is maintained in
the atrial chambers as well as in discrete components of the inﬂow
tract, including the left atrial chamber, left superior caval vein, the
pulmonary veins, and the interatrial septum (Franco et al., 2000;
Kahr et al., 2011).
The signiﬁcance of Pitx2 during heart development is illus-
trated by the complex and robust cardiac defects observed on
Pitx2 defectivemousemodels. Systemic deﬁciency of Pitx2 leads to
embryonic lethality at mid-term, leading to severe cardiovascular
defects such as double-outlet right ventricle and right atrial iso-
merism as well as incomplete closure of the body wall (Gage et al.,
1999; Lin et al., 1999; Liu et al., 2001, 2002). Isoform-speciﬁc Pitx2
mutants revealed that Pitx2c is the most relevant isoform during
cardiogenesis, since lack of Pitx2c expression, but not Pitx2a or
Pitx2b, recapitulate the morphogenetic defects similar to systemic
Pitx2-deﬁcient mice (Liu et al., 2001). More recently, with the
advent of tissue-speciﬁc conditional mutants, our understanding
of the role of Pitx2 during cardiogenesis has greatly expanded.
Ai et al. (2006) revealed that lack of Pitx2 function in the sec-
ondary heart ﬁeld, a subpopulation of cardiovascular progenitor
cells emanating from the medio-lateral cardiogenic mesoderm
(Kelly et al., 2001), leads to developmental defects reminiscent
of systemic Pitx2c null mutants. In addition, further evidence on
the role of Pitx2 within the secondary heart ﬁeld has been reported
at the arterial (Nowotschin et al., 2006; Yashiro et al., 2007) and
venous (Galli et al., 2008) poles of the heart. Importantly, Pitx2
function is not exclusive related to cardiac precursor cells but is
also relevant in differentiated cardiomyocytes as reported by Tes-
sari et al. (2008). Using αMHC-Cre driver mice, these authors
demonstrated that functional impairment of Pitx2 in cardiomy-
ocytes leads to cytoarchitectural disarray in ventricular myocytes
and to abnormal left–right expression of Bmp10 in the atria. Unex-
pectedly,αMHCCrePitx2mutants do not display atrial isomerism,
suggesting that left/right atrial morphological identity is acquired
before αMHC-Cre activation. Overall, these data demonstrate a
developmental role of Pitx2 with precursor cells as well as in
cardiomyocytes, including importantly, morphological structures
prone to trigger atrial arrhythmias, yet no evidence of such elec-
trophysiological defects was reported in these studies. Moreover,
although it is clearly established that Pitx2 plays a role in pul-
monary vein development (Mommersteeg et al., 2007), a frequent
AF foci, Pitx2 driven alterations occur in the setting of complex
cardiac abnormalities such as atrial isomerism, a condition which
is not linked to atrial arrhythmias in men. Therefore, additional
evidence is required to ﬁll the gap between Pitx2 function in the
embryo and the onset of AF.
Genetic variants at 4q25, close to the Pitx2 locus, are highly
associated with AF (Gudbjartsson et al., 2007), providing the con-
jecture thus that Pitx2 dysfunctionmight be toAF. Linkage of 4q25
AF risk variants have been consistently reported within distinct
cohorts, highlighting thus the reproducibility of these ﬁndings
(Chinchilla et al., 2011; Henningsen et al., 2011; Kiliszek et al.,
2011; Schnabel et al., 2011; Delaney et al., 2012; Liu et al., 2012;
Olesen et al., 2012). A twofold question arises from this hypothe-
sis, ﬁrst is whether the 4q25 genetic variants can modulate Pitx2
expression, a question that remains unanswered, and secondly,
whether Pitx2 impairment can lead to AF. Reports in human AF
right and left atrial biopsies demonstrated that PITX2 expression
is severely diminished in AF patients as compared to patients with
no clinical history of AF (Chinchilla et al., 2011), validating thus
the hypothesis that PITX2 is impaired in AF patients. In addi-
tion to the human data, several independent experimental studies
have provided evidences for this second issue, using subtle distinct
experimental models. Wang et al. (2010) have demonstrated that
Pitx2 haploinsufﬁciency predisposes to AF in electrically stimu-
lated adult mice with structurally normal hearts. These authors
reported a developmental link in that Pitx2 inhibits the sinoatrial
node gene program in the embryonic left atrium, by regulating
Shox2 and Nkx2.5 expression. When Pitx2 function is partially
(heterozygous) or completely (null) impaired in the embryonic
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(E12.5) mouse heart, Shox2, as well as several other sinoatrial
node markers such as Hcn4 and Tbx3, are ectopically expressed in
the forming inﬂow tract of the heart. These ﬁndings are further
underscored by the recent study of Ammirabile et al. (2012) using
a myocardiac speciﬁc conditional Pitx2 mouse model (cardiac tro-
ponin T Cre deletor mice). Thus, these observations provide a link
between the embryonic function of Pitx2 and AF.
Kirchhof et al. (2011) have recently described impaired gap and
tight junction expression in microarray analysis of the left atria of
adult Pitx2c heterozygous mutant mice which display no overt
structural and/or morphological alterations. These data provide
a putative link to AF since mutations in GJA5 (Cx40) are associ-
ated with AF (Gollob et al., 2006) and further implicate impaired
Pitx2 function at fetal and/or adult stages in predisposition to AF.
In line with these ﬁndings, recent work in our laboratory using a
Pitx2 over-expression model of embryonic stem cell-derived car-
diomyocytes (Lozano-Velasco et al., 2011) has shown that Pitx2
does not modify the expression of contractile proteins such as
actin and myosin heavy and light-chain isoforms, thus suggesting
that Pitx2 does not impair the contractile properties of cardiomy-
ocytes,but importantly,Pitx2mis-expression impairs connexin-40
expression.
In addition, our recent work using atrial-speciﬁc conditional
Pitx2 mouse mutants, in which right-sided sinoatrial node for-
mation is intact, also supports a role of Pitx2 impairment on the
onset of left-sided electrophysiological defects (Chinchilla et al.,
2011)which are prone substrates forAF.Voltage-gated sodiumand
inward rectifying K+ (Kir2.1, Kir2.2, and Kir2.3) ion channels are
abnormally expressed in the atrial myocardium both in fetal and
adult stages of atrial-speciﬁc conditional Pitx2 mouse mutants,
while cardiac morphogenesis is not compromised. Importantly,
inward rectifying K+ channel de-regulation, but not sodium, is
mediated by impaired miR-1 expression in atrial-speciﬁc condi-
tional Pitx2 mutant mice. As a consequence, in these mice, the
action potential amplitude is decreased, while the resting mem-
brane potential is more depolarized. Further evidence on the de-
regulation of ion channels by Pitx2 impairment has been recently
reported also by Kirchhof et al. (2011) using mRNA microarray
analyses in Pitx2c heterozygous adult mutant mice. Thus, these
data reveal a role for Pitx2 controlling ion channel expression, and
thus a link to atrial arrhythmogenesis, as summarized in Figure 1.
CONCLUDING REMARKS AND PERSPECTIVE
We have highlighted herein our current knowledge on the role of
Pitx2 in the developing and adult heart as well as on the state-
of-the-art link between PITX2 and AF. Several studies have shown
that Pitx2 is essential for pulmonary vein development (Mommer-
steeg et al., 2007), a highly recurrent pro-arrhythmogenic region
in humans. Experimental evidence has shown that Pitx2 is impor-
tant for transcriptional regulation in the secondary heart ﬁeld (Ai
et al., 2006), derivatives of which will form the venous pole of the
heart. Similarly, additional evidence has revealed a role of Pitx2 in
the regulation of cell-to-cell communication proteins and essen-
tial ion channels, which modulate critical aspects of the cardiac
action potential, as well as a role repressing the sinoatrial node
gene program (Wang et al., 2010; Chinchilla et al., 2011; Kirch-
hof et al., 2011). Overall, these data strongly implicate Pitx2 as
an upstream regulator of pro-arrhythmogenic events. However,
there are several missing links. The ﬁrst one is how the identi-
ﬁed genetic variants alter Pitx2 expression and to date, this point
FIGURE 1 | (A,B) Illustrations of Pitx2 expression in the developing fetal
embryo (E14.5) in longitudinal histological sections. (A) Illustrate the
expression of Pitx2 at the level of the left ventricle (lv) and left atria (la),
showing the robust expression of Pitx2 in the developing left atrial chamber,
whereas (B) illustrates the expression of Pitx2 at the level of the right
ventricle (rv) and right atrium (ra). Observe the marked contrast of expression
between the right atrium (low) and the left atrium (high) as revealed by the
arrows. Note also the dorso-ventral difference of Pitx2 expression at the
ventricular level [arrowheads, (A,B)]. (C) Schematic representation of the
current state-of-the-art role of Pitx2 in the developing and adult atrial
chambers linked to atrial arrhythmogenesis. Pitx2 controls miR-1 expression
in the left atrial chamber, providing thus a regulatory mechanism for IK1 and
Gja1 function. In addition Pitx2 regulates INa while inhibits the expression right
atrial (Bmp10) and sinoatrial (Shox2) markers in the left atrium, which in turn
play key regulatory roles on cardiomyocyte cell cycle and pacemaker activity,
providing additional links to atrial arrhythmias.
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remains unanswered. Secondly, it remains elusive how altered
Pitx2 expression would modify conductive elements leading to
the onset of AF (although new insights have progressively being
gained; Figure 1), in particular whether the impaired conductive
elements might be deregulated already from embryonic stages, as
suggested by Wang et al. (2010) and Ammirabile et al. (2012) or
exclusively in the fetal/adult heart as reported by Kirchhof et al.
(2011) and Chinchilla et al. (2011). On the basis of the develop-
mental role of Pitx2, it might be postulated that impaired Pitx2
in the developing heart might be a predisposing factor for AF.
However, an early defect in Pitx2 function would be expected to
have severe consequences for cardiac embryogenesis, and thus
it is more likely that fetal or adult dysfunction might under-
lie Pitx2 predisposition to AF. In addition, it is unclear if Pitx2
deﬁciency might also lead to impaired formation and/or func-
tion of other components of the ventricular cardiac conduction
system such as the AV node and the left and right AV bundle
branches. Morphological analysis of the ventricular conduction
system in the left–right mutant mouse model iv/iv suggests that
left/right cues can inﬂuence AV node formation (Franco and
Icardo, 2001). Nonetheless, further studies are required to demon-
strate a putative role of Pitx2 in ventricular conduction system
deployment.
Interestingly, in addition to reports linking 4q25 risk variants to
AF,newGWAShave identiﬁed several other genetic variants highly
associated with AF, which are located at 9p21, 1q21, and 16q22,
respectively. On chromosome 9p21, no candidate gene has been
linked toAF,and thus its relevance awaits further experimental and
functional evidence (Larson et al., 2007). However, genetic vari-
ants at 1q21 are linked to KCNN3 (Ellinor et al., 2011) and IL6R
(Schnabel et al., 2011), respectively whereas risk genetic variants
at 16q22 are linked to ZFHX3 (Gudbjartsson et al., 2009). To date
it remains elusive the putative involvement of these genes in the
pathophysiology of AF. A putative scenario might be that PITX2
might modulate these genes. Thus, further insights are required to
explore both the links between all GWAS associated genes as well
as the cellular and molecular mechanisms that might underlie a
functional role between KCNN3, IL6R and ZFHX3, and AF, yet
this aspect remains to be elucidated. Thus, new exciting dates are
ahead right now.
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